Combination Aesthetics Market , 2012-2023
Global Combination Aesthetics Market
Combination aesthetics therapy is also called as polytherapy that is a treatment pathway uses more than one modality The practice is not new to medicine, but is a fairly new approach in aesthetic medicine. One of the example for combination aesthetics is botulinum toxin and fillers, which is more effective when administered along with other filler than administering alone. Some of the other types of combinations are Tissue tightening plus fillers, Tissue tightening plus fractional resurfacing with carbon dioxide, cellulite remodelling with tissue tightening etc. Over recent years there has been a sharp increase in combination therapies, with many aesthetics professionals recommending combination therapies to maximise results in anti-ageing and body contouring treatments.
The major factors that are augmenting the growth of the market are; increase in adoption of minimally invasive and non-invasive process, growing demand of aesthetic treatment among male, rise in aging population, growing awareness of cosmetics procedures, and availability of user-friendly aesthetic devices, among others. However, high cost of treatment, low reimbursements, and risk of device malfunctions associated mostly with implants, low focus on combination aesthetics for the dermatological conditions, stringent regulation on aesthetics procedures and increase in adoption of branded beauty and cosmetics product are major factors that hamper the growth of global combination aesthetics market.
Combination aesthetics market are segmented on the basis of treatment, application, end-user and by region.
Based on the treatment, combination aesthetics market are segmented as:
On the basis of region presence, combination therapies in aesthetics market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America and Europe are the biggest markets for the combination therapies in aesthetics market. North America market is expected to continue to dominate over the next few years due to higher number of U.S. FDA approvals for botulinum products in the region. However, it is harder to get Health Canada approvals. Asia-Pacific market is comparatively smaller and less penetrated than other regional markets. However, it is one the fastest growing market due to rising patient awareness for various therapeutic options and increase in accessibility to these procedures. Combination treatments such wrinkle lifting plus volume restoring are gaining popularity in this region. Healthy economic growth and disposable income levels in Brunei, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam contribute largely to increasing demand for facial injectable products.
Some of the key market players in the combination therapies in aesthetics market are Merz Pharma GmbH & Co. KGaA (Germany), Biopolymer GmbH &Co KG (Germany), Revance Therapeutics Inc. (U.S.), Mentor Worldwide LLC (U.S.), Alma Lasers (Israel), Anika Therapeutics.Inc. (U.S.), Contura International A/S (Denmark), Cynosure. Inc. (U.S.), and GaldermaS.A. (Nestle) (Switzerland)
In April 2016, Galderma and Mentor Worldwide LLC, entered into new nationwide collaboration in order to partner with the surgeons globally to elevate the patient experience across the company innovative aesthetic & corrective brands and offerings
In April 2017, Allergan plc successfully completed the acquisition of ZELTIQ® Aesthetics, Inc., to strengthen its body contouring business segment
Combination aesthetics therapy is also called as polytherapy that is a treatment pathway uses more than one modality The practice is not new to medicine, but is a fairly new approach in aesthetic medicine. One of the example for combination aesthetics is botulinum toxin and fillers, which is more effective when administered along with other filler than administering alone. Some of the other types of combinations are Tissue tightening plus fillers, Tissue tightening plus fractional resurfacing with carbon dioxide, cellulite remodelling with tissue tightening etc. Over recent years there has been a sharp increase in combination therapies, with many aesthetics professionals recommending combination therapies to maximise results in anti-ageing and body contouring treatments.
The major factors that are augmenting the growth of the market are; increase in adoption of minimally invasive and non-invasive process, growing demand of aesthetic treatment among male, rise in aging population, growing awareness of cosmetics procedures, and availability of user-friendly aesthetic devices, among others. However, high cost of treatment, low reimbursements, and risk of device malfunctions associated mostly with implants, low focus on combination aesthetics for the dermatological conditions, stringent regulation on aesthetics procedures and increase in adoption of branded beauty and cosmetics product are major factors that hamper the growth of global combination aesthetics market.
Combination aesthetics market are segmented on the basis of treatment, application, end-user and by region.
Based on the treatment, combination aesthetics market are segmented as:
- Botulinum Toxin- A (BTx-A)/Dermal Filler
- Botulinum Toxin- A (BTx-A)/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal filler/Topical drug
- Others
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- Hospitals
- Ambulatory Surgical Centers
- Dermatological Clinics
On the basis of region presence, combination therapies in aesthetics market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America and Europe are the biggest markets for the combination therapies in aesthetics market. North America market is expected to continue to dominate over the next few years due to higher number of U.S. FDA approvals for botulinum products in the region. However, it is harder to get Health Canada approvals. Asia-Pacific market is comparatively smaller and less penetrated than other regional markets. However, it is one the fastest growing market due to rising patient awareness for various therapeutic options and increase in accessibility to these procedures. Combination treatments such wrinkle lifting plus volume restoring are gaining popularity in this region. Healthy economic growth and disposable income levels in Brunei, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam contribute largely to increasing demand for facial injectable products.
Some of the key market players in the combination therapies in aesthetics market are Merz Pharma GmbH & Co. KGaA (Germany), Biopolymer GmbH &Co KG (Germany), Revance Therapeutics Inc. (U.S.), Mentor Worldwide LLC (U.S.), Alma Lasers (Israel), Anika Therapeutics.Inc. (U.S.), Contura International A/S (Denmark), Cynosure. Inc. (U.S.), and GaldermaS.A. (Nestle) (Switzerland)
In April 2016, Galderma and Mentor Worldwide LLC, entered into new nationwide collaboration in order to partner with the surgeons globally to elevate the patient experience across the company innovative aesthetic & corrective brands and offerings
In April 2017, Allergan plc successfully completed the acquisition of ZELTIQ® Aesthetics, Inc., to strengthen its body contouring business segment
1. EXECUTIVE SUMMARY
2. GLOBAL COMBINATION AESTHETICS MARKET INTRODUCTION
2.1. Global Combination Aesthetics Market – Taxonomy
2.2. Global Combination Aesthetics Market –Definitions
2.2.1. Treatement Type
2.2.2. Application
3. GLOBAL COMBINATION AESTHETICS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Combination Aesthetics Market Dynamic Factors - Impact Analysis
4. GLOBAL COMBINATION AESTHETICS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL COMBINATION AESTHETICS MARKET, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Botulinum Toxin- A (BTx-A)/Laser
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Laser/Topical Drug
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Laser/Radiofrequency
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Dermal filler/Topical drug
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. GLOBAL COMBINATION AESTHETICS MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
6.1. Hair Removal
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Tattoo Removal
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Skin Resurfacing
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Scar Removal
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL COMBINATION AESTHETICS MARKET, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. Hospitals
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dermatology Clinics
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL COMBINATION AESTHETICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, and Region, 2017 – 2023
9. NORTH AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
9.1.2. Botulinum Toxin- A (BTx-A)/Laser
9.1.3. Laser/Topical Drug
9.1.4. Laser/Radiofrequency
9.1.5. Dermal filler/Topical drug
9.1.6. Others
9.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hair Removal
9.2.2. Tattoo Removal
9.2.3. Skin Resurfacing
9.2.4. Scar Removal
9.2.5. Others
9.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Dermatology Clinics
9.3.3. Ambulatory Surgical Centers
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
9.6. North America Combination Aesthetics Market Dynamics – Trends
10. EUROPE COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
10.1.2. Botulinum Toxin- A (BTx-A)/Laser
10.1.3. Laser/Topical Drug
10.1.4. Laser/Radiofrequency
10.1.5. Dermal filler/Topical drug
10.1.6. Others
10.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hair Removal
10.2.2. Tattoo Removal
10.2.3. Skin Resurfacing
10.2.4. Scar Removal
10.2.5. Others
10.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Dermatology Clinics
10.3.3. Ambulatory Surgical Centers
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
10.6. Europe Combination Aesthetics Market Dynamics – Trends
11. ASIA-PACIFIC COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
11.1.2. Botulinum Toxin- A (BTx-A)/Laser
11.1.3. Laser/Topical Drug
11.1.4. Laser/Radiofrequency
11.1.5. Dermal filler/Topical drug
11.1.6. Others
11.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hair Removal
11.2.2. Tattoo Removal
11.2.3. Skin Resurfacing
11.2.4. Scar Removal
11.2.5. Others
11.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Dermatology Clinics
11.3.3. Ambulatory Surgical Centers
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
11.6. Asia-Pacific Combination Aesthetics Market Dynamics – Trends
12. LATIN AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
12.1.2. Botulinum Toxin- A (BTx-A)/Laser
12.1.3. Laser/Topical Drug
12.1.4. Laser/Radiofrequency
12.1.5. Dermal filler/Topical drug
12.1.6. Others
12.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hair Removal
12.2.2. Tattoo Removal
12.2.3. Skin Resurfacing
12.2.4. Scar Removal
12.2.5. Others
12.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Dermatology Clinics
12.3.3. Ambulatory Surgical Centers
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
12.6. Latin America Combination Aesthetics Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
13.1.2. Botulinum Toxin- A (BTx-A)/Laser
13.1.3. Laser/Topical Drug
13.1.4. Laser/Radiofrequency
13.1.5. Dermal filler/Topical drug
13.1.6. Others
13.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Hair Removal
13.2.2. Tattoo Removal
13.2.3. Skin Resurfacing
13.2.4. Scar Removal
13.2.5. Others
13.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Dermatology Clinics
13.3.3. Ambulatory Surgical Centers
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, By Application, and Country, 2017 – 2023
13.6. MEA Combination Aesthetics Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Merz Pharma GmbH & Co. KGaA (Germany)
14.2.2. Biopolymer GmbH &Co KG (Germany)
14.2.3. Revance Therapeutics Inc. (U.S.)
14.2.4. Mentor Worldwide LLC (U.S.)
14.2.5. Alma Lasers (Israel)
14.2.6. Anika Therapeutics.Inc. (U.S.)
14.2.7. Contura International A/S (Denmark)
14.2.8. Cynosure. Inc. (U.S.)
14.2.9. GaldermaS.A. (Nestle) (Switzerland)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL COMBINATION AESTHETICS MARKET INTRODUCTION
2.1. Global Combination Aesthetics Market – Taxonomy
2.2. Global Combination Aesthetics Market –Definitions
2.2.1. Treatement Type
2.2.2. Application
3. GLOBAL COMBINATION AESTHETICS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Combination Aesthetics Market Dynamic Factors - Impact Analysis
4. GLOBAL COMBINATION AESTHETICS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL COMBINATION AESTHETICS MARKET, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Botulinum Toxin- A (BTx-A)/Laser
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Laser/Topical Drug
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Laser/Radiofrequency
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Dermal filler/Topical drug
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. GLOBAL COMBINATION AESTHETICS MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
6.1. Hair Removal
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Tattoo Removal
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Skin Resurfacing
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Scar Removal
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL COMBINATION AESTHETICS MARKET, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. Hospitals
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dermatology Clinics
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL COMBINATION AESTHETICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, and Region, 2017 – 2023
9. NORTH AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
9.1.2. Botulinum Toxin- A (BTx-A)/Laser
9.1.3. Laser/Topical Drug
9.1.4. Laser/Radiofrequency
9.1.5. Dermal filler/Topical drug
9.1.6. Others
9.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hair Removal
9.2.2. Tattoo Removal
9.2.3. Skin Resurfacing
9.2.4. Scar Removal
9.2.5. Others
9.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Dermatology Clinics
9.3.3. Ambulatory Surgical Centers
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
9.6. North America Combination Aesthetics Market Dynamics – Trends
10. EUROPE COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
10.1.2. Botulinum Toxin- A (BTx-A)/Laser
10.1.3. Laser/Topical Drug
10.1.4. Laser/Radiofrequency
10.1.5. Dermal filler/Topical drug
10.1.6. Others
10.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hair Removal
10.2.2. Tattoo Removal
10.2.3. Skin Resurfacing
10.2.4. Scar Removal
10.2.5. Others
10.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Dermatology Clinics
10.3.3. Ambulatory Surgical Centers
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
10.6. Europe Combination Aesthetics Market Dynamics – Trends
11. ASIA-PACIFIC COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
11.1.2. Botulinum Toxin- A (BTx-A)/Laser
11.1.3. Laser/Topical Drug
11.1.4. Laser/Radiofrequency
11.1.5. Dermal filler/Topical drug
11.1.6. Others
11.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hair Removal
11.2.2. Tattoo Removal
11.2.3. Skin Resurfacing
11.2.4. Scar Removal
11.2.5. Others
11.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Dermatology Clinics
11.3.3. Ambulatory Surgical Centers
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
11.6. Asia-Pacific Combination Aesthetics Market Dynamics – Trends
12. LATIN AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
12.1.2. Botulinum Toxin- A (BTx-A)/Laser
12.1.3. Laser/Topical Drug
12.1.4. Laser/Radiofrequency
12.1.5. Dermal filler/Topical drug
12.1.6. Others
12.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hair Removal
12.2.2. Tattoo Removal
12.2.3. Skin Resurfacing
12.2.4. Scar Removal
12.2.5. Others
12.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Dermatology Clinics
12.3.3. Ambulatory Surgical Centers
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
12.6. Latin America Combination Aesthetics Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
13.1.2. Botulinum Toxin- A (BTx-A)/Laser
13.1.3. Laser/Topical Drug
13.1.4. Laser/Radiofrequency
13.1.5. Dermal filler/Topical drug
13.1.6. Others
13.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Hair Removal
13.2.2. Tattoo Removal
13.2.3. Skin Resurfacing
13.2.4. Scar Removal
13.2.5. Others
13.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Dermatology Clinics
13.3.3. Ambulatory Surgical Centers
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, By Application, and Country, 2017 – 2023
13.6. MEA Combination Aesthetics Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Merz Pharma GmbH & Co. KGaA (Germany)
14.2.2. Biopolymer GmbH &Co KG (Germany)
14.2.3. Revance Therapeutics Inc. (U.S.)
14.2.4. Mentor Worldwide LLC (U.S.)
14.2.5. Alma Lasers (Israel)
14.2.6. Anika Therapeutics.Inc. (U.S.)
14.2.7. Contura International A/S (Denmark)
14.2.8. Cynosure. Inc. (U.S.)
14.2.9. GaldermaS.A. (Nestle) (Switzerland)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS